GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Yunkang Group Ltd (HKSE:02325) » Definitions » Revenue per Share

Yunkang Group (HKSE:02325) Revenue per Share : HK$1.28 (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Yunkang Group Revenue per Share?

Yunkang Group's revenue per share for the six months ended in Dec. 2024 was HK$0.60. Yunkang Group's revenue per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$1.28.

Warning Sign:

Yunkang Group Ltd revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue Per Share Growth Rate of Yunkang Group was -20.10% per year. During the past 3 years, the average Revenue Per Share Growth Rate was -27.80% per year. During the past 5 years, the average Revenue Per Share Growth Rate was -0.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Yunkang Group's Revenue per Share or its related term are showing as below:

HKSE:02325' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -27.8   Med: 16.8   Max: 81
Current: -27.8

During the past 7 years, Yunkang Group's highest 3-Year average Revenue Per Share Growth Rate was 81.00% per year. The lowest was -27.80% per year. And the median was 16.80% per year.

HKSE:02325's 3-Year Revenue Growth Rate is ranked worse than
86.36% of 198 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.95 vs HKSE:02325: -27.80

Yunkang Group Revenue per Share Historical Data

The historical data trend for Yunkang Group's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yunkang Group Revenue per Share Chart

Yunkang Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Revenue per Share
Get a 7-Day Free Trial 2.32 3.39 7.30 1.60 1.28

Yunkang Group Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 4.27 0.84 0.75 0.68 0.60

Competitive Comparison of Yunkang Group's Revenue per Share

For the Diagnostics & Research subindustry, Yunkang Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yunkang Group's PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Yunkang Group's PS Ratio distribution charts can be found below:

* The bar in red indicates where Yunkang Group's PS Ratio falls into.


;
;

Yunkang Group Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Yunkang Group's Revenue Per Share for the fiscal year that ended in Dec. 2024 is calculated as

Revenue Per Share (A: Dec. 2024 )=Revenue (A: Dec. 2024 )/Shares Outstanding (Diluted Average) (A: Dec. 2024 )
=760.059/595.863
=1.28

Yunkang Group's Revenue Per Share for the quarter that ended in Dec. 2024 is calculated as

Revenue Per Share (Q: Dec. 2024 )=Revenue (Q: Dec. 2024 )/Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
=354.404/591.124
=0.60

Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yunkang Group  (HKSE:02325) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Yunkang Group Revenue per Share Related Terms

Thank you for viewing the detailed overview of Yunkang Group's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Yunkang Group Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Yayingshi Road, Science City, Huangpu District, Guangzhou, CHN
Yunkang Group Ltd is a medical operation service provider in China. The company has three major business lines namely covering diagnostic testing services for medical consortia, diagnostic outsourcing services, and non-medical institutions.
Executives
Huizekx Limited 2201 Interest of corporation controlled by you
Yk Development Limited 2101 Beneficial owner
Zhang Yong 2201 Interest of corporation controlled by you
Shanghai Pudong Development Bank Co., Ltd 2201 Interest of corporation controlled by you
Kastle Limited 2301 Trustee
Yk Innovation Limited 2301 Trustee
Zhou Xinyu
Guang Zhou Da An Ji Yin Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Da An Guo Ji Ji Tuan You Xian Gong Si 2101 Beneficial owner
Guang Zhou Shi Da An Ji Yin Ke Ji You Xian Gong Si 2201 Interest of corporation controlled by you
Jin Jun Ying Limited 2201 Interest of corporation controlled by you
Mouduans Limited 2201 Interest of corporation controlled by you
Source Capital Rw Limited 2201 Interest of corporation controlled by you
Tongfuzc Limited 2201 Interest of corporation controlled by you
Wjjr Investment Limited 2201 Interest of corporation controlled by you

Yunkang Group Headlines

No Headlines